Tenaya Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Tenaya Therapeutics

09/09/2021 14:20

* Tenaya Therapeutics Inc  TNYA.OQ  reported a quarterly
adjusted loss of $13.26​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of $7.17 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Tenaya Therapeutics Inc's reported EPS for the quarter was a
loss of $13.26​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* The company reported a quarterly loss of $15.21 million.
* Wall Street's median 12-month price target for Tenaya
Therapeutics Inc is $37.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 9 at 01:20 p.m.
 ​All figures in US dollars unless otherwise stated